Philippines: Regulatory Flexibility Extension for the Unlisted Class B, C, and D Medical Devices in the Registrable Medical Devices List

Malaysia: Directive Overview of Natural Product Registration Based on 'Guideline on Natural Products with Modern Claim' (w.e.f 4 April 2024)

Australia: Proposed Revision of Manufacturing Principles for Medicines, Active Pharmaceutical Ingredients, and Sunscreens (w.e.f 3 June 2024)

Singapore: MOH ACE Implant Subsidy List (ISL) and HTA Process Updates

Hong Kong: MDACS Accepts Marketing Approval from Health Sciences Authority (HSA) of Singapore (w.e.f. 2 April 2024)

India: PSUR Online Submission for Medical Devices/In-Vitro Devices Marketing Authorization (w.e.f 01 April 2024)

Singapore: UDI Phase 2 Compliance Date Approaching (w.e.f 1 November 2024)

Argentina: ANMAT Reviewing Changes to Sales Conditions for Medicinal Specialties (21 March 2024)

Hong Kong: CP-05 for Listed Medical Devices Distributors by MDD (1 March 2024)